Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response

Blockade of CD200 in the Presence or Absence of Antibody Effector Function: Implications for Anti-CD200 Therapy

(2014) A. Kretz-Rommel et al.   JOURNAL OF IMMUNOLOGY

Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling

(2013) Reginald M. Gorczynski et al.   BREAST CANCER RESEARCH AND TREATMENT

Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma

(2013) Nuray Erin et al.   BREAST CANCER RESEARCH AND TREATMENT

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer

(2013) A N Seo et al.   BRITISH JOURNAL OF CANCER

Cytokine patterns in patients with cancer: a systematic review

(2013) Bodo E Lippitz   LANCET ONCOLOGY

Premetastatic soil and prevention of breast cancer brain metastasis

(2013) Y. Liu et al.   NEURO-ONCOLOGY

Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and Adhesion

(2013) Yue Geng et al.   PLoS One

CD200-expressing human basal cell carcinoma cells initiate tumor growth

(2013) Chantal S. Colmont et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci

(2013) Sachie Hiratsuka et al.   Nature Communications

Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6

(2012) Anna Podnos et al.   BREAST CANCER RESEARCH AND TREATMENT

Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer

(2012) N R West et al.   BRITISH JOURNAL OF CANCER

Soluble CD200 Is Critical to Engraft Chronic Lymphocytic Leukemia Cells in Immunocompromised Mice

(2012) K. K. Wong et al.   CANCER RESEARCH

Interleukin-6 Inhibits Regulatory T Cells and Improves the Proliferation and Cytotoxic Activity of Cytokine-induced Killer Cells

(2012) Guohe Lin et al.   JOURNAL OF IMMUNOTHERAPY

Melanoma Cell Expression of CD200 Inhibits Tumor Formation and Lung Metastasis via Inhibition of Myeloid Cell Functions

(2012) Fatemeh Talebian et al.   PLoS One

Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia

(2012) Ali Memarian et al.   TUMOR BIOLOGY

Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model

(2011) Lili Bao et al.   AMERICAN JOURNAL OF PATHOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor

(2011) T P Rygiel et al.   ONCOGENE

Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice

(2010) Reginald M. Gorczynski et al.   BREAST CANCER RESEARCH AND TREATMENT

TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion

(2010) Y Wu et al.   BRITISH JOURNAL OF CANCER

The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma

(2010) Magda Stumpfova et al.   CANCER RESEARCH

TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype

(2010) Gianluca Storci et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice

(2009) Reginald M. Gorczynski et al.   BREAST CANCER RESEARCH AND TREATMENT

Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells

(2009) M Murohashi et al.   BRITISH JOURNAL OF CANCER

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

(2009) Emmanuelle Charafe-Jauffret et al.   CANCER RESEARCH

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation

(2009) Dimitrios Iliopoulos et al.   CELL

Interleukin-10: new perspectives on an old cytokine

(2009) David M. Mosser et al.   IMMUNOLOGICAL REVIEWS

Expression of a CD200 Transgene Is Necessary for Induction but Not Maintenance of Tolerance to Cardiac and Skin Allografts

(2009) R. M. Gorczynski et al.   JOURNAL OF IMMUNOLOGY

Identification of S100A8 and S100A9 as Serological Markers for Colorectal Cancer

(2009) Hye-Jung Kim et al.   JOURNAL OF PROTEOME RESEARCH

Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6–Dependent Manner

(2008) Adam W. Studebaker et al.   CANCER RESEARCH

Altered gene expression in breast cancer liver metastases

(2008) Nuray Erin et al.   INTERNATIONAL JOURNAL OF CANCER

Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters Substance P level

(2008) Nuray Erin et al.   REGULATORY PEPTIDES